Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis

Published:2019-07-11 Issue:9 Volume:38 Page:2521-2532
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Rani Jyoti¹²,Silla Yumnam³,Borah Kasmika³,Ramachandran Srinivasan²,Bajpai Urmi¹

Affiliation:

1. Department of Biomedical Science, Acharya Narendra Dev College, University of Delhi, New Delhi, India;

2. G. N. Ramachandran Knowledge of Centre, Council of Scientific and Industrial Research – Institute of Genomics and Integrative Biology (CSIR-IGIB), New Delhi, India;

3. Advanced Computation and Data Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, India

Funder

Bioinformatics Infrastructure Facility

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2019.1637280

Reference37 articles.

1. Literature mining, ontologies and information visualization for drug repurposing

2. ATP-dependent MurE ligase in Mycobacterium tuberculosis: Biochemical and structural characterisation

3. Molecular dynamics with coupling to an external bath

4. Discovery of the first antibacterial small molecule inhibitors of MurB

5. Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Structural and Molecular Mechanisms of Mycobacterium tuberculosis Translational Elongation Factor Proteins;Molecules;2024-04-29

2. Targeting MurB from Helicobacter pylori : insights from virtual screening, molecular docking and molecular dynamics simulation;Molecular Simulation;2024-02-28

3. Pathophysiology, Current Therapeutic Options, Vaccine Candidates, and Drug Targets for Human Brucellosis;Current Molecular Pharmacology;2023-08-23

4. Multitargeting: An Alternative Approach to Tackle Multidrug Resistance in Tuberculosis;Current Drug Targets;2023-08-07

5. The Potential of Mur Enzymes as Targets for Antimicrobial Drug Discovery;Current Drug Targets;2023-08-03